Jon Zinman - 01 Jan 2026 Form 4 Insider Report for Keenova Therapeutics plc

Role
Director
Signature
/s/ Mark Tyndall, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 18:05:02 UTC
Previous filing
18 Aug 2025
Next filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zinman Jon Director 440 ROUTE 22 EAST, SUITE 302, BRIDGEWATER /s/ Mark Tyndall, Attorney-in-Fact 05 Jan 2026 0002001886

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction Ordinary Shares Options Exercise +4,384 +120% 8,031 01 Jan 2026 By JZ Advisors LLC F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Restricted Stock Units Options Exercise $0 -4,384 -11% $0.000000 35,570 01 Jan 2026 Ordinary Shares 4,384 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
F2 Shares are held directly by JZ Advisors LLC, a limited liability company, of which the Reporting Person is a 100% owner and managing member.
F3 On February 19, 2024, the Reporting Person was granted 10,942 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024. Outstanding RSUs were subsequently adjusted as described in footnote 4 below.
F4 Reflects that the Reporting Person received 6,711 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. ("Par Health") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health.

Remarks:

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.